CANAGLIFLOZIN AND DIURETIC USE IN TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE: INSIGHTS FROM THE CREDENCE TRIAL

Authors
Publication date
1 October 2022
Publisher
WILEY
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      UNSWorks

      redirect
      oaioai:unsworks.library.unsw.edu....
      Last time updated on 15/05/2024